Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000999

Drug Information
NameCinoxacin    
SynonymsST044511; Azolinic Acid; NCGC00023754-04; EINECS 249-133-8; DB00827; Compound 64716; HMS500P20; Cinoxacine; NCGC00023754-03; UNII-LMK22VUH23; AC1L1EEQ; NSC304467; Oprea1_131085; Cinobactin; NCGC00023754-06; Lopac-C-8645; Prestwick3_000780; 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; Uronorm; KBio3_001263; KBio2_000632; Cinoxacine [INN-French]; NCGC00023754-05; C8645_SIGMA; (1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-; MolPort-001-794-447; (1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1,4-dihydro-1-ethyl-4-oxo-; 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid; KBio1_000318; KBioSS_000632; cinoxacin; Cinoxacin [USAN:BAN:INN:JAN]; BRD-K14704277-001-05-1; Lopac0_000309; Lilly 64716; D00872; Spectrum_000152; BSPBio_000860; Cinoxacinum; LS-62687; Cinobac; SPECTRUM1500190; EU-0100309; NCGC00015277-04; SPBio_000360; Spectrum2_000570; SPBio_002799; BPBio1_000946; NSC 304467; NCGC00015277-01; Prestwick0_000780; NINDS_000318; AC1Q317Y; BRN 1084304; KBio2_003200; 1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; Prestwick1_000780; C08052; Spectrum5_000749; CCRIS 8206; NCGC00023754-07; CHEBI:3716; 1-Ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; NCGC00015277-14; 28657-80-9; KBio2_005768; Clinoxacin; TNP00246; NCGC00015277-02; Prestwick2_000780; C12H10N2O5; Spectrum3_000352; BSPBio_002043; NCGC00015277-03; MLS001148076; SMR000058232; CHEMBL1208; HMS2091E18; [1,3]Dioxolo[4,5-g]cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-; DivK1c_000318; 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; C 8645; CAS-28657-80-9; Spectrum4_000289; IDI1_000318; Cinoxacinum [INN-Latin]; Prestwick_239; Cinoxacino [INN-Spanish]; KBioGR_000818; NCGC00015277-07; MLS000069630; Cinoxacin (JAN/USP/INN); CID2762; Cinoxacino; HMS1920O11; Cinx; HMS1570K22; Cinobac (TN)    
IndicationUrinary tract infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntiinfective Agents    
CAS NumberCAS 28657-80-9
FormularC12H10N2O5    
PubChem Compound IDCID 2762.    
PubChem Substance IDSID 10252.    
SuperDrug ATC IDJ01MB06;    
SuperDrug CAS ID028657809;    
TargetDNA gyraseInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018067 To Reference
Ref 2The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther. 1999 Aug;290(2):672-7. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543